Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 12/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 12/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 5/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.35 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5038365 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA4CHRNB4CHRNA3POLB | |
| SCHEMBL5034040 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA4CHRNB4CHRNA3POLB | |
| SCHEMBL11963203 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA4CHRNB4CHRNA3POLB | |
| SCHEMBL5034199 | 0.86 | CHRNB2 (0.56) | CHRNB2CHRNA4AKR1C3 | |
| SCHEMBL5043514 | 0.83 | CHRNB2 (0.62) | CHRNB2CHRNA4CHRNB4CHRNA3AKR1C3 | |
| SCHEMBL5041416 | 0.83 | CHRNB2 (0.62) | CHRNB2CHRNA4CHRNB4CHRNA3AKR1C3 | |
| SCHEMBL5036829 | 0.82 | AKR1C3 (0.39) | CHRNB2CHRNA4CHRNB4CHRNA3HCAR2 | |
| SCHEMBL5036684 | 0.82 | CHRNB2 (0.57) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL6625866 | 0.82 | CHRNB4 (0.49) | CHRNB2CHRNA4CHRNB4CHRNA3AKR1C3 | |
| SCHEMBL5036628 | 0.82 | CHRNB2 (0.57) | CHRNB2CHRNA4CHRNB4CHRNA3AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1144413-B1 | 2,5-DIAZABICYCLO 2.2.1]HEPTANE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES | SANOFI SYNTHELABO (FR) | 2004-03-17 | — | — | EP | disclosed |
| US-6635645-B1 | Nicotinic receptors dysfunction | SANOFI-SYNTHELABO (FR) | 2003-10-21 | — | — | US | disclosed |